Pharmacogenomics of CYP3A: considerations for HIV treatment

Por Lakhman, Sukhwinder S, Ma, Qing, Morse, Gene D
Publicado em 2009

Global HIV/AIDS Clinical and Translational Pharmacology

Por Morse, Gene D., Maartens, Gary, Maponga, Charles Chiedza, Ma, Qing
Publicado em 2012

Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications

Por Bednasz, Cindy J., Venuto, Charles S., Qing, Ma, Morse, Gene D.
Publicado no Clin Pharmacol Drug Dev (2017)

The Impact of Herbal Drug Use on Adverse Drug Reaction Profiles of Patients on Antiretroviral Therapy in Zimbabwe

Por Mudzviti, Tinashe, Maponga, Charles C., Khoza, Star, Ma, Qing, Morse, Gene D.
Publicado em 2012

Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program

Por Mudzviti, Tinashe, Sibanda, Marvelous, Gavi, Samuel, Maponga, Charles Chiedza, Morse, Gene D.
Publicado em 2012

Emerging Nanomedicine Approaches to Targeting HIV-1 and Antiretroviral Therapy

Por Kutscher, Hilliard L., Prasad, Paras N., Morse, Gene D., Reynolds, Jessica L.
Publicado no Future Virol (2016)

Antiretroviral bioanalysis methods of tissues and body biofluids

Por DiFrancesco, Robin, Maduke, Getrude, Patel, Rutva, Taylor, Charlene R, Morse, Gene D
Publicado em 2013

Disulfiram Metabolite S-Methyl-N, N-Diethylthiocarbamate Quantitation in Human Plasma with Reverse Phase Ultra Performance Liquid Chromatography and Mass Spectrometry

Por Hochreiter, Jill, McCance-Katz, Elinore F., Lapham, Jill, Ma, Qing, Morse, Gene D.
Publicado em 2012

The impact of herbal remedies on adverse effects and quality of life in HIV-infected individuals on antiretroviral therapy

Por Bepe, Nyasha, Madanhi, Nathan, Mudzviti, Tinashe, Gavi, Samuel, Maponga, Charles Chiedza, Morse, Gene D
Publicado em 2011

Comparative Effectiveness of Darunavir 1,200 mg Daily and Approved Dosing Strategies for Protease Inhibitor-Experienced Patients

Por Mikula, James M., Hsiao, Chiu-Bin, Sawyer, Joshua R., Ma, Qing, Morse, Gene D.
Publicado em 2013

Lack of Pharmacokinetic Interactions Between Pitavastatin and Efavirenz or Darunavir/Ritonavir

Por Malvestutto, Carlos D., Ma, Qing, Morse, Gene D., Underberg, James A., Aberg, Judith A.
Publicado no J Acquir Immune Defic Syndr (2014)

Capacity for ethical and regulatory review of herbal trials in developing countries: a case study of Moringa oleifera research in HIV-infected patients

Por Monera-Penduka, Tsitsi G., Maponga, Charles C., Morse, Gene D., Nhachi, Charles F. B.
Publicado no J Pharm Policy Pract (2017)

Quality Assurance Program for Clinical Measurement of Antiretrovirals: AIDS Clinical Trials Group Proficiency Testing Program for Pediatric and Adult Pharmacology Laboratories

Por Holland, Diane T., DiFrancesco, Robin, Stone, Judith, Hamzeh, Fayez, Connor, James D., Morse, Gene D.
Publicado em 2004

Effects of Valproic Acid Coadministration on Plasma Efavirenz and Lopinavir Concentrations in Human Immunodeficiency Virus-Infected Adults

Por DiCenzo, Robert, Peterson, Derick, Cruttenden, Kim, Morse, Gene, Riggs, Garret, Gelbard, Harris, Schifitto, Giovanni
Publicado em 2004

Antiretroviral drug levels and interactions affect lipid, lipoprotein and glucose metabolism in HIV-1 seronegative subjects: A pharmacokinetic-pharmacodynamic analysis

Por Rosenkranz, Susan L., Yarasheski, Kevin E., Para, Michael F., Reichman, Richard C., Morse, Gene D.
Publicado em 2007

Ultra-performance liquid chromatography tandem mass spectrometry for determination of Direct Acting Antiviral drugs in human liver fine needle aspirates

Por Ocque, Andrew J., Hagler, Colleen E., DiFrancesco, Robin, Morse, Gene D., Talal, Andrew H.
Publicado no J Chromatogr B Analyt Technol Biomed Life Sci (2017)

Pharmacokinetics of Ritonavir and Delavirdine in Human Immunodeficiency Virus-Infected Patients

Por Shelton, Mark J., Hewitt, Ross G., Adams, John, Della-Coletta, Andrew, Cox, Steven, Morse, Gene D.
Publicado em 2003

Lack of Clinically Significant Drug Interactions between Nevirapine and Buprenorphine

Por McCance-Katz, Elinore F., Moody, David E., Morse, Gene D., Ma, Qing, Rainey, Petrie M.
Publicado em 2010

Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral Nanoformulations

Por Makita-Chingombe, Faithful, Kutscher, Hilliard L., DiTursi, Sara L., Morse, Gene D., Maponga, Charles C.
Publicado no J Drug Deliv (2016)

Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals

Por Nwogu, Jacinta Nwamaka, Ma, Qing, Babalola, Chinedum Peace, Adedeji, Waheed Adeola, Morse, Gene D., Taiwo, Babafemi
Publicado no AIDS Res Treat (2016)